Immunobiology of mucosal HIV-1 infection

Current Opinion in Gastroenterology

Volumn 12, Issue 6, 1996, Pages 560-563

  Li, Ling ^a   Smith, Phillip D ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL MUCOSA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBIOLOGY; PATHOGENESIS; REVIEW;

EID: 0029822747     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199611000-00012     Document Type: Review

References (40)

1. Smith PD: Mucosal immunopathophysiology of HIV infection. In Handbook of Mucosal Immunology. Edited by Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J. Orlando: Academic Press; 1994:719-728. A review of the virologic and immunologic events that occur in the mucosa during the early, intermediate, and late stages of HIV-1 infection and a discussion of how these events predispose the host to the gastrointestinal manifestations of HIV-1 disease.
2. Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, Nagelkerke NJD, Maitha G, Holmes KK, Piot P, Pamba HO, Plummer FA: Mother-to-child transmission of human immunodeficiency virus type 1 : report from the Nairobi study. J Infect Dis 1994, 170:1134-1140. The overall risk of HIV-1 transmission from 365 mothers to their 363 children was shown by serologic evidence to be 42.8%, and the percentage of HIV-1 infection attributable to breast feeding up to 15 months and beyond was 32%.
3. Padian N, Shibosky N, Jewell N: Female to male transmission of human immunodeficiency virus. JAMA 1991, 266:1664-1667.
4. Temmerman M, ALi FM, Ndinya-Achola J, Moses S, Plummer FA, Piot P: Rapid increase of both HIV-1 infection and syphilis among pregnant women in Nairobi, Kenya. AIDS 1992, 6:1181-1185.
5. Rosenberg RS: Scope of the AIDS epidemic in the United States. Science 1995, 270:1372-1375. Although the estimated incidence of HIV-1 infection has declined markedly over time among white males, particularly those older than 30 years, the incidence has remained constant among women and minorities and has actually increased to 3% of black men and 1% of black women in their thirties.
6. Ryder R, Nsa W, Hassig SE, Behets F, Rayfield M, Ekungola B, Nelson AM, Mulenda U, Francis H, Mwandagalirwa K, Davachi F, Rogers M, Nzilambi N, Greenberg A, Mann J, Quinn TC, Piot P, Curran JW: Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989, 320:1637-1642.
7. The European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 1991, 339:1007-1012.
8. European Collaborative Study: Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991, 1:253-260.
9. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, Garcia P, Fowler MG, Mofenson L, Tuomala R: Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996, 334:1617-1623.
10. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD: Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993, 261:1179-1181.
11. Zhang LQ, McKenzie P, Cleland A, Holmes EC, Brown AJL, Simmonds P: Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993, 63:3345-3356.
12. Chesbro B, Wehrly K, Nishino J, Perryman S: Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogenicity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992, 66:6547-6554.
13. Wolinsky SM, Wike CM, Korber BTW, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Munoz JL: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255:1134-1136.
14. Roos MTL, Lange JMA, DeGoede REY, Coutinho RA, Schellekens PTA, Miedema F, Tersmette M: Virus phenotype and immune response in primary human immunodeficiency virus type 1 (HIV-1) infection. J Infect Dis 1992, 165:427-432.
15. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996, 183:215-225.
16. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Cruz VP, Chui D-S, Osathanondh R, Mayer K, Lee T-H, Essex M: HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996, 271:1291-1293.
17. Maric H, Holt PG, Perdue MH, Bienenstock J: Class II MHC antigen (la)-bearing dendritic cells in the epithelium of the rat intestine. J Immunol 1996, 156:1408-1414.
18. Kelsall BL, Strober W: Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996, 183:237-247.
19. Frankel SS, Wenig BM, Burke AP, Mannan P, Thompson LDR, Abbondanzo SL, Nelson AM, Pop M, Steinman RM: Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996, 272:115-117.
20. Tsunoda R, Hashimoto K, Baba M, Shigeta S, Sugai N: Follicular dendritic cells in vitro are not susceptible to infection by HIV-1. AIDS 1996, 10:595-602.
21. Langhoff E, Kalland KH, Haseltine WA: Early molecular replication of human immunodeficiency virus type 1 in cultured-blood-derive T helper dendritic cells. J Clin Invest 1993, 91:2721-2726.
22. Heath SL, Tew JG, Szakal AK, Burton GF: Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995, 377:740-744. Follicular dendritic cells are shown to trap HIV-1 on their surface and to convert HIV-1 neutralized by antibody into highly infectious virus.
23. Baba TW, Koch J, Mittler ES, Greene M, Wyand M, Penninck D, Ruprecht RM: Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res Hum Retroviruses 1994, 8:351-357.
24. Baba TW, Trichel AM, An L, Liska V, Martin LN, Murphey-Corb M, Ruprecht RM: Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 1996, 272:1486-1489.
25. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM: Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995, 96:456-464. Saliva is shown to inhibit HIV-1 infection of monocytes. Among the salivary proteins examined, only secretory leukocyte protease inhibitor strongly inhibited HIV-1 infection of monocytes and, to a lesser extent, lymphocytes.
26. Amerongen HM, Weltzin R, Farnet CM, Michetti P, Haseltine WA, Neuta MR: Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr 1991, 4:760-765.
27. Wahl SM, Orenstein JM, Smith PD: Macrophage functions in HIV-1 infection. In Immunology of Human Immunodeficiency Virus Type 1 Infection. Edited by Gupta SD. New York: Plenum Press; 1996:303-336. Most current and thorough review to date of the immunobiology of HIV-1 infection of macrophages.
28. Lee SH, Starkey PM, Gordon S: Quantitative analysis of total macrophage content in adult mouse tissues: immunochemical studies with monoclonal antibody F4/80. J Exp Med 1984, 161:475-489.
29. Smith PD, Fox CH, Masur H, Winter HS, Ailing DW: Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med 1994, 180:1541-1546.
30. Lu SS, Kotler DP: HIV infection and the gut Curr Opin Gastroenterol 1995, 11:525-531.
31. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane. G protein-coupled receptor. Science 1996, 272:872-877. Evidence presented in this article documents the presence of a surface cofactor called fusin, which mediates fusion and entry of preferentially T-cell-line tropic isolates.
32. Deng HK, Lui R, Ellmeir W, Choe S, Unutmaz D, Burkhart M, Marzio PD, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR: Identification of a major co-receptor for primary isolated of HIV-1. Nature 1996, 381:661-666.
33. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
34. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC-CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958. This and the preceding two articles present conclusive evidence that CC-CKR-5, a receptor for RANTES and macrophage inflammatory proteins 1α and 1β, is the fusion cofactor for macrophage-tropic HIV-1.
35. + T cells. Science 1995, 270:1811-1815.
36. + lymphocytes from highly exposed but uninfected persons to HIV-1 infection is shown to correlate with the in vitro production of increased levels of β chemokines (RANTES, macrophage inflammatory proteins 1α and 1β).
37. Janoff EN, Jackson S, Wahl SM, Thomas K, Peterman JH, Smith PD: Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection. J Infect Dis 1994, 170:299-307.
38. Kozlowski PA, Black KP, Shen L, Jackson S: High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. J Immunol 1995, 154:6163-6173.
39. Janoff EN, Wahl SM, Thomas K, Smith PD: Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA. J Infect Dis 1995, 172:855-888.
40. Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS: Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis 1996, 173:60-67.